Infermedica

Infermedica is a healthcare technology company that develops artificial intelligence solutions for symptom assessment, clinical triage, patient intake, and care navigation. Founded in 2012, the company focuses on helping healthcare providers, hospitals, health insurance companies, telemedicine services, public health organisations, and other healthcare businesses improve the way patients access medical services. Its technology is designed to support the early stages of the healthcare journey by collecting information about a patient’s health, assessing reported symptoms, identifying possible conditions, and recommending an appropriate level of care.

The company’s central offering is its Medical Guidance Platform, an AI-powered healthcare system that combines medical knowledge, clinical reasoning, and software technology. Rather than functioning as a general-purpose chatbot, Infermedica is designed around structured medical information and clinically reviewed content. Its platform can be incorporated into websites, mobile applications, patient portals, telehealth services, and contact-centre workflows. This allows healthcare organisations to provide digital health guidance through channels that patients already use.

One of Infermedica’s main solutions is its clinical AI triage technology. The system collects information from patients through digital interviews, chat-based interactions, voice experiences, or forms. It asks relevant follow-up questions based on the answers provided, helping to build a clearer picture of the patient’s reported symptoms and health history. The inference engine then analyses the collected information and produces possible explanations for the symptoms, an assessment of urgency, and recommendations about the type of healthcare service the patient may need.

The triage process is intended to help patients understand where to seek care. Depending on the information collected, the platform can direct users towards self-care information, telemedicine, a general practitioner, a specialist, or more urgent medical attention. This can help healthcare organisations manage patient demand and reduce confusion about the appropriate point of entry into their services. The technology is designed to support clinical workflows rather than replace professional diagnosis or the judgement of qualified healthcare practitioners.

Infermedica’s Certified AI Triage solution provides a ready-to-use approach for organisations that want to introduce digital symptom assessment and care navigation. It uses structured medical interviews and clinical logic to gather patient information and guide users towards suitable care options. Healthcare providers can incorporate the solution into their existing digital services, allowing patients to complete an initial assessment before contacting a medical professional or selecting a healthcare service. The company also provides options for adapting the experience to an organisation’s branding and service requirements.

Another important product is Infermedica Intake, which focuses on collecting structured patient information before a medical consultation. Instead of requiring patients to explain their entire medical situation from the beginning of an appointment, the intake workflow can gather relevant details in advance. These may include symptoms, medical history, risk factors, and other information needed for a consultation. The collected information can help healthcare professionals prepare for appointments and reduce some of the administrative work involved in patient registration and consultation preparation.

The intake solution is particularly relevant to hospitals, clinics, telemedicine providers, and healthcare networks that handle large numbers of patient appointments. By collecting information before a visit, organisations can give clinicians a more organised starting point for conversations with patients. The technology can also support the transfer of structured information into larger healthcare systems, depending on the integration arrangement and the data fields supported by the implementation.

Infermedica also provides Follow-up capabilities for maintaining engagement after an initial patient interaction. Follow-up interviews can help organisations collect updated information about a patient’s symptoms and reassess their reported condition over time. This can support ongoing patient communication and help healthcare teams understand whether a patient’s situation has changed since an earlier assessment. Follow-up workflows can be incorporated into broader digital care journeys, although the exact process depends on how the healthcare organisation configures its implementation.

The company offers two principal API options: Platform API and Engine API. These products give developers different levels of flexibility when building healthcare applications. Platform API provides a more structured approach with preconfigured patient interviews and workflows, including triage, intake, and follow-up. It is designed for organisations that want to introduce established healthcare journeys without developing every part of the experience independently.

Engine API provides a more flexible option for organisations that want to build their own symptom assessment and patient guidance applications. Developers can use its endpoints to collect medical evidence, search medical concepts, analyse symptoms, estimate possible conditions, determine triage levels, recommend specialists, and access additional medical information. This makes it suitable for building custom symptom checkers, medical chatbots, patient portals, and other digital healthcare applications.

The Infermedica inference engine is a central part of these solutions. It processes information supplied during a patient interview and determines which additional questions may be relevant. As the interview progresses, the system analyses the available evidence and updates its assessment. Its outputs can include possible conditions, triage recommendations, and suggested healthcare services. The engine is designed to provide consistent results based on its structured medical knowledge and the information supplied to it.

Infermedica’s medical knowledge base supports the reasoning process. It contains information about symptoms, conditions, risk factors, and other medical concepts used by the platform. The company’s documentation describes coverage for adults and children, including separate medical content for paediatric use. Infermedica reports that its technology includes more than 3,000 medical concepts and has received extensive physician input and validation. The company also reports more than 160,000 hours of physician involvement in its medical technology development and validation work.

Natural language processing is another important component of the platform. It helps the system interpret medical information expressed in ordinary language and convert relevant details into structured medical concepts. This can be useful when patients describe symptoms in their own words or when healthcare organisations want to process information from existing medical records and consultation notes. The technology can help identify relevant symptoms, medical history, and possible conditions from supported text-based information.

Infermedica also provides tools for patient education and clinical explanations. Depending on the selected product and API implementation, healthcare applications can present information that helps users understand the assessment results and recommended next steps. These capabilities can make digital health experiences more informative and help patients communicate their concerns more clearly when they contact healthcare professionals.

For healthcare providers and insurers, Infermedica’s technology can support digital front-door services. A digital front door is an online entry point through which patients can access healthcare information, complete an initial assessment, and find an appropriate service. By introducing symptom assessment before a patient books an appointment or contacts a call centre, organisations can improve how incoming requests are organised. The platform can also help direct patients towards available services based on the needs identified during an assessment.

The technology is also designed for call-centre and nurse-triage environments. Healthcare contact centres often receive enquiries from people who are unsure about the type of care they need. Infermedica can support these workflows by collecting structured information and presenting clinical guidance to trained staff. This can help improve consistency in patient interviews and reduce the amount of time spent gathering basic information. The final decisions about patient care remain within the responsibilities of qualified healthcare professionals and the organisation’s clinical procedures.

Infermedica’s platform can be adapted for different healthcare organisations. Healthcare providers can use it to support patient intake and triage, while health plans and insurers can incorporate it into member-support services. Telemedicine companies can use symptom assessment to help patients prepare for remote consultations. Public health organisations can use digital assessment tools to improve access to health information, while pharmaceutical companies may explore relevant patient-support applications. The appropriate use depends on the selected product, regulatory requirements, and the organisation’s intended workflow.

Integration is another important part of Infermedica’s offering. The company provides API-based connections that allow developers to incorporate its technology into existing websites, mobile applications, patient portals, and healthcare systems. Its integration approach supports standards such as HL7 and FHIR, which are widely used for exchanging healthcare information. The platform also uses medical terminology mappings based on ICD-10 and SNOMED CT to support structured data exchange between different systems.

Through its integration capabilities, organisations can transfer selected patient information into an assessment workflow and return relevant results to their existing systems. Supported information can include demographic details, investigated symptoms, possible conditions, triage levels, care recommendations, and specialist suggestions. Depending on the implementation, results can be delivered as structured information, plain text, or PDF summaries for inclusion in patient records.

The company also provides a developer portal with API documentation, reference materials, implementation guidance, and examples. Developers can review the available endpoints, understand authentication requirements, configure their applications, and test supported workflows. The documentation includes resources for both Platform API and Engine API, as well as a Postman collection and a user-interface component library. These resources can help technical teams understand how to connect Infermedica’s clinical technology to their own applications.

Multilingual support is another important capability. Infermedica states that its products support 26 languages, helping healthcare organisations serve patients in different markets. Its published Symptom Checker language list includes Arabic, Chinese (Simplified), Czech, Dutch, English, Estonian, French, German, Greek, Italian, Latin American Spanish, Polish, Portuguese, Brazilian Portuguese, Romanian, Russian, Slovak, Spanish, Turkish, and Ukrainian. The developer documentation also describes additional language models and regional variations for API implementations. The availability of particular languages depends on the product and selected plan, and organisations should confirm the language coverage they require before implementation.

Infermedica places considerable emphasis on clinical safety, medical content review, and information security. Its current Medical Guidance Platform is certified as a Class IIb medical device under the European Union Medical Device Regulation. The company also identifies standards and compliance frameworks including ISO 13485, ISO 27001, GDPR, HIPAA, and SOC 2 Type 2. These credentials are relevant to healthcare organisations evaluating technology that processes patient information and contributes to clinical workflows. Actual compliance responsibilities still depend on the implementation, contractual arrangements, and the organisation using the service.

The company reports that its technology has supported more than 30 million health checkups and is used by over 100 healthcare organisations and partners across more than 35 countries. It also publishes case studies involving healthcare providers, insurers, and other organisations. These examples demonstrate how its technology can be applied to patient navigation, digital triage, pre-visit information collection, and healthcare contact-centre support. Reported performance figures are company-provided measures and should be considered in the context of the relevant product, evaluation method, and clinical setting.

Infermedica is not intended to replace hospitals, doctors, nurses, or other qualified medical professionals. Its main purpose is to provide structured digital support for symptom assessment, patient information collection, and care navigation. The technology can help patients and healthcare organisations organise information and identify appropriate next steps, but its results should be used within suitable clinical and operational processes. Patients should not rely on an automated assessment as a substitute for professional medical advice, diagnosis, or emergency care.

The company also maintains a consumer-facing health application called Symptomate, which provides free online and mobile symptom-checking experiences. This is separate from the enterprise-focused Medical Guidance Platform and its commercial products. Organisations looking to implement Infermedica’s technology in their own systems generally need to discuss the available products, licensing, language requirements, and integration arrangements with the company.

Infermedica is best suited to healthcare organisations and developers that need clinical AI capabilities for digital triage, patient intake, symptom assessment, and care navigation. Its combination of medical knowledge, structured interviews, APIs, multilingual content, and healthcare integration standards makes it relevant to organisations building digital primary-care services. Its enterprise focus means it is not simply a general-purpose application that every individual can subscribe to and customise independently.

Pricing

Infermedica does not publish a fixed public price list for its commercial healthcare solutions. Pricing depends on the products selected, required features, implementation scope, and the number of language versions an organisation needs.

• Enterprise solutions – Custom pricing: Certified AI Triage, Intake, Follow-up, and other Medical Guidance Platform services are priced according to the organisation’s requirements.
• Platform API – Custom pricing: Access is arranged through Infermedica’s sales team, with pricing depending on the selected plan and implementation.
• Engine API – Custom pricing: Developers and organisations must contact Infermedica to discuss API access and available plans.
• API trial – Available on request: Eligible applicants can request trial access that includes up to 2,000 API calls. Continued use requires an appropriate paid plan.
• Symptomate – Free: Infermedica’s separate consumer-facing symptom-checking service is available for free use on web and mobile.

Review

Infermedica is a specialised healthcare technology platform that focuses on clinical symptom assessment, patient triage, and digital care navigation. Its strongest advantage is its combination of structured medical knowledge and AI-driven reasoning. Rather than operating as a general chatbot, it uses medical concepts, patient information, and clinically reviewed content to support healthcare workflows.

Its product range is another strength. Certified AI Triage, Intake, Follow-up, Platform API, and Engine API address different stages of the patient journey. Organisations can choose a more structured implementation or build a custom application using the available APIs. This flexibility makes Infermedica relevant to hospitals, insurers, telemedicine providers, healthcare networks, and developers building digital health services.

The integration capabilities also make the platform useful for organisations with established healthcare systems. Support for FHIR, HL7, ICD-10, and SNOMED CT can help connect patient information and assessment results with other applications. Its developer documentation, API references, and Postman resources provide technical teams with a foundation for implementation.

Multilingual medical content is another advantage, particularly for organisations serving patients across different regions. The availability of multiple language models can help healthcare providers offer more accessible digital assessment experiences. However, organisations should confirm the exact language availability for their chosen product rather than assuming every feature supports every language.

Infermedica also demonstrates a strong focus on clinical governance and security. Its Medical Guidance Platform has EU MDR Class IIb certification, and the company identifies several healthcare-related quality and information-security standards. These are important considerations for organisations evaluating clinical technology that may influence patient navigation and healthcare operations.

However, Infermedica is not a low-cost self-service tool with publicly listed monthly subscriptions. Commercial pricing requires direct contact with the company, and the final cost can depend on the selected products, features, languages, and implementation requirements. Smaller organisations and independent developers may find this process less straightforward than using a product with transparent public pricing.

Implementation can also require technical and clinical planning. Organisations may need developers, healthcare professionals, integration specialists, and compliance teams to configure the platform appropriately. Connecting it to existing patient portals, electronic health records, or contact-centre systems can involve additional work. The company also identifies implementation support as a paid service, so customers should clarify whether technical assistance is included in their agreement.

Another important consideration is that AI-generated assessments are not a substitute for professional medical judgement. The technology can support symptom analysis and care navigation, but organisations must establish appropriate clinical oversight, escalation procedures, and patient communication. They should also evaluate the system against their own patient population and operational requirements.

Infermedica is a strong option for healthcare organisations seeking a specialised platform for digital triage, patient intake, and symptom assessment. Its clinical focus, multilingual capabilities, API flexibility, and healthcare integration standards make it more suitable for professional healthcare environments than for casual personal use. Its custom pricing and implementation requirements may be barriers for smaller teams, but organisations with the resources to deploy it can use its capabilities to support more organised digital patient journeys.